Metastatic Non-Small Cell Lung Cancer with Alexander Drilon, MD: Case 2

Video

Metastatic Non-Small Cell Lung Cancer with Alexander Drilon, MD

Case Scenario 2:

SR is a 58 year-old female, former smoker 20 PPY (stopped smoking 5 years ago), presents with cough and SOB. She experienced an unintended 10 lb weight loss over a 3-month period.

  • Tissue analysis identified adenocarcinoma, EGFR, ALK, ROS1 negative.
  • PD-L1 expression was < 50%.
  • Patient has stage IV disease with metastasis to the liver.
  • A chest CT scan confirmed the primary mass in the upper lobe of the right lung, with several pleural metastases and malignant pleural effusion.
  • MRI of the brain was negative for intracranial metastases.
  • Patient has not complained of blood in the sputum.
  • Patient has history of well controlled HTN.
  • Her performance status was 1 at diagnosis.

Patient was started on carboplatin/paclitaxel/bevacizumab for 4 cycles. Patient showed partial response and was continued on bevacizumab until progression.

Related Videos
Video 3 - "Managing Toxicities and Adverse Reactions in HR+/Her2-Low mBC Therapies"
Video 2 - "EMERALD: Underscoring Key Elacestrant Data + Subgroup Analyses for Informed Therapy Selection"
Video 1 - "A 62-Year-Old Woman with HR+ HER2-low Metastatic Breast Cancer and Lung, Liver, and Bone Metastases and Using Biomarker Testing to Guide Treatment Selection"
John Mascarenhas, MD, an expert on myelofibrosis
John Mascarenhas, MD, an expert on myelofibrosis
Related Content